Ok, so we still see insane full page ads in the NYT accusing immunization of inducing a plague of autism. On the other hand, where's the panic about our drug supplies?
F.D.A. Broke Its Rules by Not Inspecting Chinese Plant With Problem Drug - New York Times
... Baxter International announced on Monday that it was suspending sales of its multidose vials of heparin after four patients died and 350 suffered complications, many of them serious. Baxter bought the active ingredient for this product from Scientific Protein Laboratories, which has plants in Waunakee, Wis., and Changzhou City, China...
... Ms. Gardiner said that recent tests by Baxter had found subtle chemical differences among the lots that Scientific Protein shipped to Baxter “but it is unclear what impact the differences would have” on Baxter’s heparin product.
Dr. Ajay Singh, director of dialysis at the Brigham and Women’s Hospital in Boston, said he was astonished by what he called the many failures to ensure a safe supply of heparin. There are 450,000 people in the United States on dialysis, and nearly all of them need copious doses of heparin, he said. Heparin is also used in cardiac surgery and among chronic care patients.
“We need to ensure that this country has access to the crucial medicines it needs,” Dr. Singh said. “This is a national security issue.”
The heparin scare comes at a particularly delicate time for the F.D.A. Over the past year, a wave of tainted goods from China, including deadly pet food ingredients and tainted fish, has prompted concern about whether regulators are adequately monitoring imports’ safety.
The Government Accountability Office released three reports in recent months that found that the drug agency provided little oversight of the increasing number of foreign plants that export food, drugs and devices to the United States.
Although the agency must inspect domestic drug plants once every two years, the investigators found that it inspected foreign drug plants at best once every 13 years. The agency’s record in China, now one of the biggest drug suppliers in the world, is even worse. Of the 700 approved Chinese drug plants, the agency has been able to inspect only 10 to 20 each year and would need 40 to 50 years to inspect them all.
Update 2/15/2008: If our medication supply is having quality issues, they would not all be as obvious as fatalities. They might only show up in large scale studies ...